Skip to main content

Table 1 Frequencies of any diagnosis of COVID-19, entry to critical care and fatal outcome among those eligible for shielding, by eligibility category, up to 18 February 2021

From: Relation of severe COVID-19 in Scotland to transmission-related factors and risk conditions eligible for shielding support: REACT-SCOT case-control study

  

Diagnosed with COVID-19

 
 

Not diagnosed with COVID-19

No critical care, non-fatal

Critical care, non-fatal

Fatal

All

All shielding categories

204,703 (96.2%)

6081 (2.9%)

359 (0.2%)

1559 (0.7%)

212,644

Shielding eligibility category

Solid organ transplant

6620 (96.3%)

188 (2.7%)

24 (0.3%)

40 (0.6%)

6872

Specific cancers

25,788 (96.6%)

652 (2.4%)

36 (0.1%)

223 (0.8%)

26,699

Severe respiratory

83,268 (96.2%)

2432 (2.8%)

131 (0.2%)

768 (0.9%)

86,599

Rare diseases

10,673 (96.4%)

300 (2.7%)

14 (0.1%)

85 (0.8%)

11,072

On immunosuppressants

30,796 (96.8%)

866 (2.7%)

42 (0.1%)

103 (0.3%)

31,807

Additional conditions

47,501 (95.8%)

1642 (3.3%)

112 (0.2%)

340 (0.7%)

49,595

  1. Percentages are row percentages
  2. Severe cases are those that entered critical care or were fatal